| Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897) |
|---|
| 06/12/2002 | EP1211955A1 A nutritional supplement for lowering serum triglyceride and cholesterol levels |
| 06/12/2002 | EP0656894B2 Isolation of tocopherol and sterol |
| 06/12/2002 | CN1353113A Active component of achyranthes root, its preparation and medical usage and its preparing process |
| 06/06/2002 | US20020068834 Reacting unsaturated alkyl ketone with chiral oxazaborolidine compound to form unsaturated alkyl alcohol; intermediates for production of squalamine |
| 06/05/2002 | EP1210359A2 A process for the preparation of 3-amino bile acid derivatives |
| 06/04/2002 | US6399796 Activation of a Diels-Alder reaction of a sterol 5,7-diene |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 05/28/2002 | US6395722 Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/28/2002 | CA2104780C Lipid fractionation |
| 05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
| 05/22/2002 | EP0966434B1 Aminophenol derivatives and their use in cosmetics |
| 05/22/2002 | CN1350543A 14 beta-H-sterols, PHarmaceutical composiutions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments |
| 05/22/2002 | CN1349757A Health foods |
| 05/21/2002 | US6392068 Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery |
| 05/16/2002 | US20020058827 Partial glycerides are subjected to a first transesterification step under mild conditions and, after working up and the removal of impurities, the sterol esters are subjected to a second transesterification |
| 05/16/2002 | US20020058649 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose |
| 05/14/2002 | US6387411 Concurrent melting |
| 05/10/2002 | WO2001026618A3 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 05/09/2002 | US20020055493 Phytosterol and/or phytostanol derivatives |
| 05/08/2002 | EP1059851B1 Stable homogeneous emulsifier-free suspension, preparation method and uses in food compositions |
| 05/08/2002 | EP0975656B1 Process for the preparation of stanol esters |
| 05/07/2002 | US6384251 5-ene steroids such as dehydroepiandrosterone; ketone products |
| 05/07/2002 | US6384025 Skin disorders; reacting retinol with chloroformate compound |
| 05/07/2002 | US6384024 Bile salt conjugates |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/02/2002 | WO2001049280A3 Weight promoting composition, method, and product |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 04/30/2002 | US6380408 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3 |
| 04/30/2002 | US6379698 Fusogenic lipids and vesicles |
| 04/25/2002 | US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers. |
| 04/24/2002 | EP1198994A2 Health food products |
| 04/24/2002 | CN1345727A Aqueous soluble steroid compound alkaloid salt, preparation process and medicinal composition containing same |
| 04/18/2002 | US20020045773 Hydrogenating a sterol blend in a hydrogenation solvent; removing the hydrogenation catalyst from the obtained hot reaction solution by transesterifying with a fatty acid methyl ester at an elevated temperature |
| 04/18/2002 | US20020045772 E.g., 2 beta-(2-iodoethyloxy)-1 alpha ,3 beta ,25-tris(triethylsilyloxy)cholesta-5,7-diene |
| 04/17/2002 | EP0783514B1 Sterol compositions from pulping soap |
| 04/11/2002 | WO2002028396A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 04/11/2002 | US20020042927 Meiosis activating sterol augments implantation rate |
| 04/10/2002 | CN1344272A Method for producing 4,4-dimethyl-3 beta-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 04/09/2002 | US6369247 Process for oxidation of steroidal compounds having allylic groups |
| 04/03/2002 | EP1192175A2 Method of treating organic substances |
| 04/03/2002 | EP0988312B1 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 04/02/2002 | US6365579 Nitrate esters and their use for neurological conditions |
| 03/27/2002 | EP1189924A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 03/27/2002 | EP1189922A1 Steroid derivatives |
| 03/26/2002 | US6361791 Stable aqueous dispersions including cationic lipids |
| 03/21/2002 | WO2002006205B1 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 03/20/2002 | CN1341147A Method for in vitro fertilisation of meiosis activating sterols (mas) |
| 03/14/2002 | US20020032179 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder |
| 03/13/2002 | CN1340071A Double metal cyanide catalysts for producing polyether polyols |
| 03/13/2002 | CA2319230A1 Improved method of extraction of tall oil soap |
| 03/07/2002 | US20020028803 Controlling cell apoptosis |
| 03/07/2002 | US20020028793 Antilipemic agents, anticholesterol agents, anticoagulants |
| 03/06/2002 | CN1338462A Chemical synthesis of echinocystic saponin derivative |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/28/2002 | DE10037515C1 Removal of sterols from lipid matrix by extraction with compressed lower hydrocarbons, useful e.g. for removing cholesterol from fats or oils or for recovering biologically active sterol derivatives |
| 02/26/2002 | US6350738 Gramnegative bactericides; fungicides, viricides; gonane derivatives with nitrogen-containing substituent(s) |
| 02/21/2002 | WO2002014342A1 Steroid derived antibiotics |
| 02/21/2002 | WO2001049703A3 Substituted sapogenins and their use |
| 02/21/2002 | US20020022197 Using polymer |
| 02/21/2002 | DE10038457A1 Verfahren zur Gewinnung von Sterinen und Tocopherolen A process for the production of sterols and tocopherols |
| 02/21/2002 | DE10038456A1 Verfahren zur Gewinnung von Sterinen A process for the production of sterols |
| 02/21/2002 | DE10038442A1 Verfahren zur Gewinnung von Sterinen aus fettsäurehaltigen Rückständen A process for recovering sterols from the fatty acid residues containing |
| 02/20/2002 | EP1180035A1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3? |
| 02/20/2002 | CN1336824A Use of anti-inflammatory steriods for the treatment of chronic iniflammatory intestinal diseases |
| 02/20/2002 | CN1079393C Aminophenol derivatives and their use in cosmetics |
| 02/14/2002 | WO2002012222A1 Method for obtaining or recovering sterols and tocopherols |
| 02/14/2002 | WO2002011720A1 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures |
| 02/14/2002 | WO2001076531A3 Bile acid containing prodrugs with enhanced bioavailability |
| 02/14/2002 | US20020019549 Reduction; chelation |
| 02/14/2002 | US20020019547 Skin disorders; reacting retinol with chloroformate compound |
| 02/14/2002 | US20020019376 Steroid derived antibiotics |
| 02/13/2002 | EP1179536A2 Process for the isolation of sterols from the residues of fatty-acid or methyl-ester production |
| 02/13/2002 | EP1179535A1 Process for the isolation of sterines |
| 02/13/2002 | EP1179005A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 02/09/2002 | CA2316330A1 Estrone and estrone esters as growth- and fat-deposition promoting compounds in humans |
| 02/09/2002 | CA2316328A1 Improved method of hydrogenation of sterols |
| 02/07/2002 | US20020016311 Nitrate esters and their use for neurological conditions |
| 02/06/2002 | EP1177205A1 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS |
| 02/06/2002 | EP1177159A1 Fluorination in liquid or supercritical carbon dioxide |
| 02/06/2002 | CN1334738A Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 01/31/2002 | US20020013302 Sterol derivative compounds, structurally related to natural compounds which can be extracted from bull testes and from human follicular fluid, for regulating meiosis in oocytes and in male germ cells; use in treating infertility, |
| 01/31/2002 | US20020012683 Cosmetic composition comprising at least one ingredient chosen from compounds of formula (1) and salts thereof, use thereof as colouring agent, and novel compounds of formulae (IIa), (IIIa), (IVa), (Va), and (VIa), and salts thereof |
| 01/29/2002 | US6342489 Treatment of iron deficiency with ferric salt of bis hemisuccinylursodeoxycholic acid |
| 01/24/2002 | WO2002006205A1 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 01/24/2002 | US20020010349 Preparation of sterol and stanol-esters |
| 01/23/2002 | EP1173464A2 Process of purifying phytosterols from wood or plant-derived sources by means of metal salt complexes and compositions resulting therefrom |
| 01/23/2002 | EP1173463A1 Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation |
| 01/23/2002 | EP0839046B1 Tnf receptor and steroid hormone dhea in a combined therapy |
| 01/23/2002 | CN1078072C Use of 1 alpha, 24-dihydroxy vitamin D2 |
| 01/22/2002 | US6340688 Administering to female during menstrual cycle amount of competitive progesterone antagonist which is less than ovulation-inhibiting dose and less than abortion-inductive dose |
| 01/17/2002 | US20020007079 Meiosis regulating compounds |
| 01/15/2002 | US6339077 Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereof |
| 01/09/2002 | EP1170012A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb 1? |
| 01/09/2002 | EP1169335A1 Method for producing phytosterols from reduced quantities of methanol by crystallization |
| 01/09/2002 | EP1169043A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones |
| 01/03/2002 | US20020002295 Novel (meth) acrylic acid ester compound |
| 01/03/2002 | US20020002294 Antitumor agents |
| 01/03/2002 | US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents |